Market jump after Fed rate hike is a ‘trap,’ Morgan Stanley’s Mike Wilson warns investors

Market jump after Fed rate hike is a ‘trap,’ Morgan Stanley’s Mike Wilson warns investors


Morgan Stanley is urging investors to resist putting their money to work in stocks despite the market’s post-Fed-decision jump.

Mike Wilson, the firm’s chief U.S. equity strategist and chief investment officer, said he believes Wall Street’s excitement over the idea that interest rate hikes may slow sooner than expected is premature and problematic.

“The market always rallies once the Fed stops hiking until the recession begins. … [But] it’s unlikely there’s going to be much of a gap this time between the end of the Fed hiking campaign and the recession,he told CNBC’s “Fast Money” on Wednesday. “Ultimately, this will be a trap.”

According to Wilson, the most pressing issues are the effect the economic slowdown will have on corporate earnings and the risk of Fed over-tightening.

“The market has been a bit stronger than you would have thought given the growth signals have been consistently negative,” he said. “Even the bond market is now starting to buy into the fact that the Fed is probably going to go too far and drive us into recession.”

‘Close to the end’

Wilson has a 3,900 year-end price target on the S&P 500, one of the lowest on Wall Street. That implies a 3% dip from Wednesday’s close and a 19% drop from the index’s closing high hit in January.

His forecast also includes a call for the market to take another leg lower before getting to the year-end target. Wilson is bracing for the S&P to fall below 3,636, the 52-week low hit last month.

“We’re getting close to the end. I mean this bear market has been going on for a while,” Wilson said. “But the problem is it won’t quit, and we need to have that final move, and I don’t think the June low is the final move.”

Wilson believes the S&P 500 could fall as low as 3,000 in a 2022 recession scenario.

“It’s really important to frame every investment in terms of ‘What is your upside versus your downside,'” he said. “You’re taking a lot of risk here to achieve whatever is left on the table. And, to me, that’s not investing.”

Wilson considers himself conservatively positioned — noting he’s underweight stocks and likes defensive plays including health care, REITs, consumer staples and utilities. He also sees merits of holding extra cash and bonds at the moment.

And, he’s not in a rush to put money to work and has been “hanging out” until there are signs of a trough in stocks.

“We’re trying to give them [clients] a good risk-reward. Right now, the risk-reward, I would say, is about 10 to one negative,” Wilson said. “It’s just not great.”

Disclaimer



Source

Stocks making the biggest moves midday: Apple, Cleveland-Cliffs, Oracle, KLA, Tempus AI and more
Finance

Stocks making the biggest moves midday: Apple, Cleveland-Cliffs, Oracle, KLA, Tempus AI and more

Check out the companies making the biggest moves midday: Apple — The Tim Cook-led company climbed 4% after the iPhone 17 series outsold the iPhone 16 series in China and the U.S. in the first 10 days of availability, according to Counterpoint research, and Loop Capital upgraded the stock to buy from hold, citing better-than-expected […]

Read More
Stocks making the biggest moves premarket: Cleveland-Cliffs, Liberty Energy, Hologic & more
Finance

Stocks making the biggest moves premarket: Cleveland-Cliffs, Liberty Energy, Hologic & more

Check out the companies making headlines before the bell. Cleveland-Cliffs — Shares jumped 10.5% as the steel company posted its third-quarter results. Cleveland-Cliffs reported adjusted EBITDA of $143 million, topping a FactSet estimate of $127.9 million. The company also issued capital expenditures guidance of around $525 million for the year, less than a prior forecast […]

Read More
Activist investor Jana Partners takes stake in medical device maker Cooper Companies, WSJ says
Finance

Activist investor Jana Partners takes stake in medical device maker Cooper Companies, WSJ says

Barry Rosenstein, founder of JANA Partners. Adam Jeffery | CNBC Activist investor Jana Partners has taken a stake in medical device maker Cooper Companies and will push the firm to explore strategic options, the Wall Street Journal reported Monday. Shares of Cooper Companies jumped 6% in premarket trading Monday. Stock Chart IconStock chart icon Cooper […]

Read More